Gsk (GSK) Goodwill (2009 - 2026)
Gsk (GSK) posted quarterly Goodwill of $9.9 billion for Q2 2026, up 10.24% year-over-year from $9.0 billion in Q2 2025, and up 0.8% quarter-over-quarter from $9.8 billion in Q1 2026.
Gsk (GSK) Goodwill (2009 - 2026) Analysis & Trends
Gsk's Goodwill history runs 18 years deep, the most recent figure standing at $9.9 billion for Q2 2026.
- In Q2 2026, Goodwill rose 10.24% year-over-year to $9.9 billion; the TTM figure through Jun 2026 stood at $9.9 billion (up 10.24% YoY), while the FY2025 annual figure was $9.3 billion, up 3.68% from the prior year.
- Goodwill for Q2 2026 stood at $9.9 billion, up from $9.8 billion in the prior quarter.
- The five-year high for Goodwill was $11.1 billion in Q1 2022, with the low at $7.4 billion in Q2 2022.
- The 5-year median for Goodwill is $8.8 billion (2024), against an average of $8.9 billion.
- The sharpest annual moves came in 2022 and 2023: Goodwill sank 49.01% in 2022, then increased 13.0% in 2023.
- Gsk's Goodwill stood at $8.3 billion in 2022, then gained by 2.29% to $8.5 billion in 2023, then rose by 6.01% to $9.0 billion in 2024, then gained by 4.17% to $9.3 billion in 2025, then gained by 6.08% to $9.9 billion in 2026.
- Business Quant data shows GSK's Goodwill at $9.9 billion in Q2 2026, $9.8 billion in Q1 2026, and $9.3 billion in Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.88 Bn | 625.12 Bn | 17.26 Bn |
| 2 | AbbVie | 463.46 Bn | 456.89 Bn | 12.70 Bn |
| 3 | Merck | 367.92 Bn | 360.78 Bn | 12.21 Bn |
| 4 | Novartis Ag | 297.71 Bn | 290.02 Bn | 11.24 Bn |
| 5 | Astrazeneca | 255.55 Bn | 250.65 Bn | 12.86 Bn |
| 6 | Amgen | 234.52 Bn | 220.53 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 178.22 Bn | 175.04 Bn | 6.22 Bn |
| 8 | Pfizer | 158.57 Bn | 146.88 Bn | 10.94 Bn |
| 9 | Gsk | 105.32 Bn | 101.15 Bn | 8.24 Bn |
| 10 | Sanofi | 54.20 Bn | 46.82 Bn | 10.79 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 9.90 Bn |
| Mar 31, 2026 | 9.82 Bn |
| Dec 31, 2025 | 9.34 Bn |
| Sep 30, 2025 | 9.60 Bn |
| Jun 30, 2025 | 8.98 Bn |
| Mar 31, 2025 | 8.72 Bn |
| Dec 31, 2024 | 8.96 Bn |
| Sep 30, 2024 | 8.68 Bn |
| Jun 30, 2024 | 8.79 Bn |
| Mar 31, 2024 | 8.85 Bn |
| Dec 31, 2023 | 8.45 Bn |
| Sep 30, 2023 | 8.83 Bn |
| Jun 30, 2023 | 8.40 Bn |
| Mar 31, 2023 | 8.33 Bn |
| Dec 31, 2022 | 8.26 Bn |
| Sep 30, 2022 | 8.48 Bn |
| Jun 30, 2022 | 7.44 Bn |
| Mar 31, 2022 | 11.11 Bn |
| Dec 31, 2021 | 14.22 Bn |
| Sep 30, 2021 | 14.59 Bn |